PFS
REGN icon

Prospera Financial Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Prospera Financial Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.56M Sell
4,113
-554
-12% -$377K 0.04% 448
2026
Q1 		$3.61M Buy
4,667
+115
+3% +$88K 0.06% 348
2025
Q4 		$3.51M Sell
4,552
-4,214
-48% -$2.86M 0.06% 334
2025
Q3 		$4.93M Sell
8,766
-5,367
-38% -$3.03M 0.08% 250
2025
Q2 		$7.42M Buy
14,133
+10,320
+271% +$5.76M 0.14% 161
2025
Q1 		$2.42M Buy
3,813
+115
+3% +$79.1K 0.06% 349
2024
Q4 		$2.63M Buy
3,698
+2,958
+400% +$2.48M 0.06% 314
2024
Q3 		$778K Buy
+740
New +$824K 0.02% 577
2023
Q1 		– Sell
-600
Closed -$433K – 995
2022
Q4 		$433K Buy
+600
New +$443K 0.02% 573
2022
Q3 		– Sell
-70
Closed -$41K – 1412
2022
Q2 		$41K Buy
70
+2
+3% +$1.3K ﹤0.01% 1073
2022
Q1 		$47K Buy
+68
New +$43K ﹤0.01% 1404
2020
Q4 		– Sell
-141
Closed -$79K – 1352
2020
Q3 		$79K Sell
141
-1,262
-90% -$765K 0.03% 477
2020
Q2 		$875K Sell
1,403
-624
-31% -$354K 0.08% 253
2020
Q1 		$990K Buy
+2,027
New +$836K 0.11% 204

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Prospera Financial Services's REGN Position: Q2 2026 in Review

Prospera Financial Services reduced its Regeneron Pharmaceuticals (REGN) stake by 12% in Q2 2026, selling an estimated $377K and leaving 4,113 shares worth $2.56M. The position accounts for 0.04% of the portfolio, ranked #448.

Prospera Financial Services first reported a position in REGN in Q1 2020 and has held it in 14 quarters since. The position peaked at $7.42M in Q2 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Prospera Financial Services held 4,113 shares of Regeneron Pharmaceuticals worth $2.56M as of Q2 2026.
  • Prospera Financial Services sold 554 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $377K.
  • Regeneron Pharmaceuticals made up 0.04% of Prospera Financial Services's portfolio in Q2 2026, its #448 holding.
  • Prospera Financial Services first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 14 quarters since.
  • Prospera Financial Services's Regeneron Pharmaceuticals position peaked at $7.42M in Q2 2025.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.